Amize 12.5 mg/5 mg Tablet
By Amize
Rx
10 Tablet in a Strip

Composition
Amitriptyline(12.5mg) + Chlordiazepoxide(5mg)

Manufacturer - Hi Tech Pharmaceuticals Pvt Ltd
6015 Unity Dr, Norcross, GA 30071, USA

Expires on or after
July, 2026

liver
When using Amize 12.5 mg/5 mg Tablet, caution should be exercised in patients with liver disease. It may be necessary to adjust the dosage of Amize 12.5 mg/5 mg Tablet in such cases. It is important to consult your doctor regarding the use of this medication if you have any liver issues.

kidney
Limited data suggests Amize 12.5 mg/5 mg Tablet is likely safe for patients with kidney disease. Dose adjustment may not be necessary. Consult your doctor for guidance.

alcohol
It is unsafe to drink alcohol while taking Amize 12.5 mg/5 mg Tablet. Avoid alcohol intake with this medication.

driving
Caution should be taken while driving as Amize 12.5 mg/5 mg Tablet may cause drowsiness and affect concentration, potentially impacting your driving ability.

pregnancy
Amize 12.5 mg/5 mg Tablet is considered unsafe during pregnancy due to potential risks to the developing baby. However, in life-threatening situations, a doctor may prescribe it if benefits outweigh risks. Always consult your doctor before using.

breastfeeding
Caution is advised when breastfeeding while taking Amize 12.5 mg/5 mg Tablet as it may not be safe. Limited data indicates the drug may pass to the baby through breastmilk, potentially causing harm.
| Habit Forming | Yes |
| Chemical Class | - |
| Therapeutic Class | NEURO CNS |
| Action Class | - |
₹32
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 01-Oct-2024
